Product Images Bisoprolol Fumarate And Hydrochlorothiazide

This is a description of a pharmaceutical product identified by the National Drug Code 0093-3241-01. It is a medication containing Bisoprolol Fumarate and Hydrochlorothiazide in the form of tablets, and it is only available with a prescription. Each tablet has 2.5 mg of Bisoprolol Fumarate and 6.25 mg of Hydrochlorothiazide. The dosage instructions are included in the package brochure. It should be stored between 20°C to 25°C (68°F to 77°F) and dispensed in a tight container. The product is distributed by Teva Pharmaceuticals USA, Inc, based in Parsippany, NJ, and manufactured in Bulgaria. The text also contains a Serialization Coding Area for tracking purposes.*

This is a medication called Bisoprolol Fumarate and Hydrochlorothiazide Tablets. Each tablet contains 5 mg of Bisoprolol Fumarate and 6.25 mg of Hydrochlorothiazide. This medication is only available on prescription and comes in a tight container of 100 tablets. For the complete instructions of use, refer to the accompanying brochure. The medication should be stored at 20°C to 25°C (68°F to 77°F) and should be kept away from direct sunlight. This medication is distributed by Teva Pharmaceuticals USA, Inc. and manufactured in Bulgaria.*

This is a medication called Bisoprolol Fumarate and Hydrochlorothiazide. Each tablet contains 10mg of Bisoprolol Fumarate and 6.25mg of Hydrochlorothiazide. It is distributed by Teva Pharmaceuticals USA and the dosage instructions can be found in the accompanying package brochure. This medication should be stored in a tight container at a temperature of 20°C to 25°C. It comes in a unit of-use container with 30 tablets. The output also contains lot information that may be relevant for pharmaceutical tracking purposes.*